# Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites

Study · id `cardio:ct-nct01669382` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01669382](<https://clinicaltrials.gov/study/NCT01669382>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01669382

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 304 participants.

## Technical summary

Registry record NCT01669382. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 304 participants (enrolled count; ClinicalTrials.gov record NCT01669382, source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01669382, source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01669382, source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)
- Completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01669382, source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT01669382, source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01669382-2015-02-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites
- Condition: Acute Coronary Syndromes
- Condition: Stable Angina Pectoris
- Intervention (Device): percutaneous coronary intervention
- Lead sponsor: University Hospital Erlangen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)

## Provenance

Content hash: 0ab676913ac735b69350ac7e91a9555d36c8a88ba05f1ab8262404ddb3524da5
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
